BBIO

BBIO P/E Ratio
P/E Ratio as of Oct 29, 2026: -19.82
Average-18.81
Median-18.79
Minimum-19.85
Maximum-17.74
-19.82
1.33 (7.19%)past month
The P/E ratio for BBIO is -19.82 as of Oct 29, 2026. This represents a increase of 6.50% compared to its 12-month average P/E ratio of -18.61. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
BridgeBio Pharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
BridgeBio Pharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing BridgeBio Pharma Inc to industry peers.
BridgeBio Pharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
BridgeBio Pharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing BridgeBio Pharma Inc to industry peers.
BBIO P/E Ratio Insights
See BridgeBio Pharma Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BBIO
Order type
Buy in
Order amount
Est. shares
0 shares
BBIO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $66.91 | -18.75 |
| Sep 1, 2026 | $76.57 | -21.46 |
| Aug 3, 2026 | $79.96 | -21.35 |
| Jul 1, 2026 | $74.52 | -19.89 |
| Jun 1, 2026 | $65.36 | -17.45 |
| May 1, 2026 | $68.56 | -18.12 |
| Apr 1, 2026 | $74.45 | -19.67 |
| Mar 2, 2026 | $65.50 | -17.31 |
| Feb 2, 2026 | $78.24 | -18.69 |
| Jan 2, 2026 | $78.235 | -18.69 |
BBIO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -19.82 | +8.48% |
| 2025 | -18.27 | +60.54% |
| 2024 | -11.38 | +10.16% |
| 2023 | -10.33 | +355.07% |
| 2022 | -2.27 | -46.84% |
| 2021 | -4.27 | — |
FAQs About BridgeBio Pharma Inc (BBIO) P/E ratio
The latest P/E ratio of BBIO is -19.82, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
BridgeBio Pharma Inc’s last 12-month average P/E ratio is -18.61, compared to its current P/E ratio of -19.82. This reflects a increase of 6.50%.
BridgeBio Pharma Inc’s current P/E ratio of -19.82 is higher than its last 12-month average P/E of -18.61. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
BridgeBio Pharma Inc’s average P/E ratio over the last 3 years is -13.12. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
BridgeBio Pharma Inc’s average P/E ratio over the last 5 years is -9.69. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
BBIO P/E Ratio Insights
See BridgeBio Pharma Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BBIO
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.